The results showed that the C-siPlk1 conjugant was successfully internalized by tumor cells without an axillary agent and suppressed the Plk1 gene both in vitro and in vivo with much higher efficiency than non-viral gene delivery methods such as Lipofectamine 2000. Here, PLK1 is linked to neoplasm.